KURA Shares Outstanding History



Below is a table of the KURA shares outstanding history going back to 5/11/2015:

Date KURA Shares Outstanding
5/11/201514.51M
8/12/201514.51M
11/5/201518.26M
11/13/201521.37M
3/11/201621.37M
5/6/201621.37M
8/4/201621.37M
11/2/201621.37M
3/10/201721.38M
5/12/201721.41M
8/2/201721.37M
11/3/201730.22M
3/9/201833.35M
5/4/201833.35M
8/3/201837.98M
10/31/201838.04M
3/1/201938.17M
5/3/201938.18M
7/30/201945.21M
8/26/2015990000
11/1/201945.31M
2/20/202045.43M
4/30/202045.44M
8/3/202056.28M
11/2/202056.71M
2/19/202166.21M
5/3/202166.27M
8/2/202166.30M
11/1/202166.56M
2/18/202266.61M
4/29/202266.64M
7/29/202266.89M
10/27/202266.90M
2/17/202368.44M
5/4/202368.44M
8/3/202374.24M
10/26/202374.27M
2/20/202476.14M

Also see: KURA Market Cap History
KURA YTD Return
KURA Historical Shares Outstanding:
+20.77% CAGR
KURA Historical Shares Outstanding: +20.77% CAGR

Mouse over chart for data details
5/11/2015 ...2/20/2024
Kura Oncology is a clinical-stage biopharmaceutical company engaged in developing medicines for the treatment of cancer. Co.'s primary product candidate, ziftomenib, is a selective, reversible and oral small molecule inhibitor which blocks the interaction of two proteins, menin and the protein expressed by the Lysine K-specific Methyl Transferase 2A gene. Co.'s second product candidate, tipifarnib, is a selective and orally bioavailable inhibitor of farnesyl transferase. Co. is evaluating tipifarnib in multiple solid tumor and hematologic indications. We show 38 historical shares outstanding datapoints in our coverage of KURA's shares outstanding history.

Understanding the changing numbers of KURA shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like KURA versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching KURA by allowing them to research KURA shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree KURA Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Kura Oncology (KURA) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

KYMR Shares Outstanding History
KZR Shares Outstanding History
LAB Shares Outstanding History
LABP Shares Outstanding History
LBPH Shares Outstanding History
LCI Shares Outstanding History
LENZ Shares Outstanding History
LEXX Shares Outstanding History
LFMD Shares Outstanding History
LFST Shares Outstanding History
More Healthcare companies »

 

KURA Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.